Immunoassay Systems - Global Strategic Business Report 2017 - Increasing Use of Immunoassays in Food Sciences and Quality Control - Research and Markets

DUBLIN, April 26, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Immunoassay Systems - Global Strategic Business Report" report to their offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Immunoassay Systems in US$ Thousand by the following Technology Segments:

• Enzyme Immunoassay
• Fluorescence Immunoassay
• Chemiluminescence Immunoassay
• Rapid Tests
• ELISPOT
• PCR
• Others.
  

The report profiles 65 companies including many key and niche players such as:

• Abbott Laboratories (USA)
• Beckman Coulter, Inc. (USA)
• bioMérieux SA (France)
• Bio-Rad Laboratories Inc. (USA)
• DiaSorin S.p.A (Italy)
• Fujirebio, Inc. (Japan)
• Ortho-Clinical Diagnostics, Inc. (USA)
• Roche Diagnostics (Switzerland)
• Siemens Healthineers (USA)
• Sysmex Corporation (Japan)
• Quidel Corporation (USA)
• Tosoh Bioscience, Inc. (USA)
  

Key Topics Covered:

1. INDUSTRY OVERVIEW

• Immunoassays
• A Preface
• Current and Future Analysis
• Factors Sustaining Market Growth
• Factors Restraining Growth
• Developing Markets to Drive Sales
• Radioimmunoassay Systems Lose Ground
• Chemiluminescence Immunoassays Gain Demand
• Expanding Immunoassay Applications Boost Demand
  

2. COMPETITIVE LANDSCAPE

3. MARKET TRENDS AND ISSUES

• Bespoke Solutions Energize Market Growth
• Multiplex Immunoassays Grow in Demand
• Novel Biomarkers to Boost Market Growth
• SERS
• An Attractive Readout Strategy
• Automated Immunoassay Systems
• In Line with Automation Trend
• Technological Advances to buoy ELISA's Prospects
• Automation of ELISA
• Enabling its Sustenance
• Growing Popularity of Multiplexing Deters ELISA Market
• Commoditization: A Key Issue Facing ELISA Product Manufacturers
• Consolidation of Hospitals and Labs Drives Demand
• POC and DIA Systems Grow in Demand
• Prenatal Testing
• An Opportunity Market
• Rise in Infectious Diseases Raises Demand
• Increasing Use of Immunoassays in Food Sciences and Quality Control
• Growing Use in Environmental Testing

4. MACRO GROWTH DRIVERS AND APPLICATION MARKETS

• Improving Healthcare Expenditure to Foster Growth
• Blood Processing Market
• Cancer Testing Markets
• Drugs of Abuse Testing Market
• Therapeutic Drug Monitoring
• Immune Disease
• Blood Grouping and Typing

5. CONCEPTUAL OVERVIEW

6. PRODUCT LAUNCHES/APPROVALS

• Sekisui Diagnostics Launches new SEKURE® TPLA and RPR Assays for Syphilis Testing
• Siemens Healthineers Introduces Atellica Solution automated Immunoassay Analyzer System
• Abbott Introduces Alinity
• Roche Introduces New Cobas e 801 Module
• Siemens to Release Genetic Assay for Detection of Zika Virus
• Fujirebio Europe Releases the Lumipulse G B - R - A - H - M - S PCT Assay
• Fujirebio Releases "Lumipulse L 2400" CLIA System
• Roche Introduces Elecsys® HTLV-I/II Immunoassay
• Siemens Introduces ADVIA Centaur Syphilis Assay
• Sysmex Introduces HISCL-800 Automated Immunoassay System
• Siemens Introduces New Chemistry & Immunoassay Systems
• Meso Scale Discovery Launches S-PLEX Assays
• Modern Water Monitoring Introduces New Immunoassay Strip Test and Readers
• Enzo Life Sciences Launches Amp'd ELISA Signal Amplification Kit
• EMD Millipore Rolls Out New Immunoassay Kits
• PerkinElmer Launches Novel Research Tools
• Roche Releases Elecsys Syphilis Immunoassay

7. RECENT INDUSTRY ACTIVITY

• Abbott Receives CE Mark for Alinity CI-Series Diagnostic Systems
• Quidel Receives FDA Clearance for New Solana(R) Molecular Assay
• Quidel Receives FDA Clearance for Solana(R) Strep Complete Assay
• FDA Clears ORTHO VISION® Max Analyzer for High-Volume Transfusion Medicine Labs
• Beckman Coulter Receives FDA Clearance for Access TSH (3rd IS) Assay
• Quidel Receives FDA Clearance for Solana(R) Influenza A+B Assay
• Ortho Clinical Diagnostics Receives CE Mark Approval for VITROS® Immunodiagnostic HIV Combo Test
• Siemens Healthcare Changes Name to Siemens Healthineers
• DiaSorin to Acquire Focus Diagnostics' Molecular and Immunoassay Product Business
• Quidel Receives CE Mark for Quidel's Sofia® S. pneumoniae Fluorescent Immunoassay
• DiaSorin and Beckman Coulter Sign Agreement to Distribute Hepatitis and HIV Tests in China
• bioMérieux Receives FDA 510(k) clearance for VIDAS® 3
• Quidel Receives FDA Clearance for New Solana Molecular System and Solana Molecular Assay
• Siemens Receives FDA Approval for Siemens HIV Combo assay
• Eurofins Acquired ViraCor-IBT Laboratories
• YSL Bio Signs Enters into Agreement with GeneX
• Techne to Acquire CyVek
• Gyros Enters into Distribution Agreement with Tekon Biotech
• Singulex Partners with Tecan
• OriGene Technologies Takes Over BioCheck
• Techne Partners with Fisher Scientific

8. FOCUS ON SELECT MARKET PARTICIPANTS

9. GLOBAL MARKET PERSPECTIVE

For more information about this report visit http://www.researchandmarkets.com/research/rs4bzt/immunoassay

Media Contact:

Laura Wood, Senior Manager
[email protected] 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com